Biolinq Inc. received $62 million fudning from the investors according to the SEC form registered.
Stability Health received $7.2 million funding from the investors according to the SEC form registered.
Freespira, Inc., maker of the first FDA-cleared digital therapeutic that significantly reduces or eliminates symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 days, announced it has completed a $10 million capital raise led by Lightspeed Venture Partners. Joining the financing round, the largest in the company’s history, were previous investors Aphelion Capital, Medvest Capital, and Freespira Chairman, Russell Siegelman.
Lucine, a French startup offering a digital therapeutic for chronic pain, has raised $6.6 million (€5.5 million) in new funds from Kurma Partners, Bpifrance's Autonomous Patient Fund, BNP Paribas Développement, Aquiti Gestion and Irdi Soridec. The company's app uses face recognition and AI to quantify the user's pain and deliver personalized treatments such as cognitive behavioral therapy. With the new money, Lucine said it will be putting together new clinical studies for its product.
Intermountain Ventures, the strategic investment arm of Intermountain Healthcare has invested in digital care leader Omada Health. The announcement expands the relationship with Intermountain Healthcare that began five years ago in 2016 and comes off the heels of Omada’s recent $73M funding round. The Omada Program became a covered benefit for Intermountain employees and their adult dependents in 2019.
Kaia Health, a digital therapeutics startup that creates accessible, evidence-based treatments for a range of disorders including back pain and COPD, today announced it has raised $8M in funding led by Optum Ventures, part of UnitedHealth Group (UHG). The funding marks the second significant investment for Optum Ventures in the digital therapeutics space this year.
#mobile app
#coaching
Click Therapeutics announces a $17 million financing round led by Sanofi Ventures. Click will use this financing to continue advancing its proprietary platform and pipeline of prescription digital therapeutics to treat a wide range of diseases. Recent notes were converted to equity as part of the financing.
#mobile app
#pdt
#software
Propeller Health, a digital therapeutics company, toay announced a $20 million funding round led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One. Propeller plans to use the proceeds from the funding to support Propeller's investment in its pipeline of digital therapeutics and additional connected devices for the treatment of chronic respiratory disease, an area of continued market growth for the company. PropellerRead More
Mensia Technologies, French MedTech startup, leads the new booming category of Digital therapeutics with its revolutionary « at home « neurofeedback, to train the brain and cure neuropsy disorders without drugs. Co-founder INRIA-IT2, existing shareholders and now HARA, which are business angels experts in medical device category, joined this fundraising. BPI de Rennes is also part of this tour.
French startup Tilak Healthcare, which is developing video games intended to diagnose and follow-up with chronic diseases, has raised $2.7 million (2.5 million euros) from the iBionext Growth Fund. The fund is part of the French management company iBionext network, which identifies, funds and helps expand healthcare startups.